Alerts will be sent to your verified email
Verify Email
VENUSREM
|
Venus Remedies
|
Prevest Denpro
|
Medicamen Biotech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
8.87 % | 19.0 % | 6.92 % |
|
5yr average Equity Multiplier
|
1.32 | 1.07 | 1.44 |
|
5yr Average Asset Turnover Ratio
|
0.96 | 0.6 | 0.55 |
|
5yr Avg Net Profit Margin
|
6.91 % | 29.64 % | 8.69 % |
|
Price to Book
|
1.07 | 5.8 | 2.58 |
|
P/E
|
11.17 | 32.41 | 57.93 |
|
5yr Avg Cash Conversion Cycle
|
46.96 Days | 42.6 Days | 49.75 Days |
|
Inventory Days
|
75.64 Days | 36.0 Days | 84.58 Days |
|
Days Receivable
|
54.28 Days | 44.41 Days | 139.4 Days |
|
Days Payable
|
58.86 Days | 39.32 Days | 264.75 Days |
|
5yr Average Interest Coverage Ratio
|
396.11 | 99.71 | 7.03 |
|
5yr Avg ROCE
|
8.42 % | 25.39 % | 10.34 % |
|
5yr Avg Operating Profit Margin
|
10.14 % | 36.91 % | 15.51 % |
|
5 yr average Debt to Equity
|
0.08 | 0.0 | 0.15 |
|
5yr CAGR Net Profit
|
-6.01 % | 2.94 % | -11.57 % |
|
5yr Average Return on Assets
|
6.69 % | 17.71 % | 4.73 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
41.76 % | 73.6 % | 40.46 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -2.75 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Venus Remedies
|
Prevest Denpro
|
Medicamen Biotech
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|